Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-218
Closed -$16.2K 1363
2025
Q4
$16.2K Buy
+218
New +$15.9K ﹤0.01% 1378
2023
Q2
Sell
-8,401
Closed -$678K 630
2023
Q1
$678K Buy
8,401
+2,476
+42% +$199K 0.06% 288
2022
Q4
$443K Buy
+5,925
New +$422K 0.05% 370
2020
Q4
Sell
-529
Closed -$35K 1040
2020
Q3
$35K Buy
529
+9
+2% +$570 ﹤0.01% 962
2020
Q2
$29K Hold
520
﹤0.01% 1015
2020
Q1
$18K Hold
520
﹤0.01% 1062
2019
Q4
$27K Hold
520
﹤0.01% 1016
2019
Q3
$26K Buy
520
+60
+13% +$2.95K 0.01% 995
2019
Q2
$22K Buy
460
+200
+77% +$9.25K ﹤0.01% 1034
2019
Q1
$12K Buy
260
+60
+30% +$2.71K ﹤0.01% 1235
2018
Q4
$8K Sell
200
-329
-62% -$13.5K ﹤0.01% 1300
2018
Q3
$22K Hold
529
﹤0.01% 1081
2018
Q2
$21K Buy
+529
New +$20.3K ﹤0.01% 1077

Other funds holding HOLX

Flagship Harbor Advisors's HOLX Position: Q1 2026 in Review

Flagship Harbor Advisors sold out of Hologic (HOLX) in Q1 2026, closing a stake of 218 shares — an estimated $16.2K sold.

Flagship Harbor Advisors first reported a position in HOLX in Q2 2018 and held it in 13 quarters. The position peaked at $678K in Q1 2023. 704 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.

  • Flagship Harbor Advisors reported no remaining Hologic position as of Q1 2026 after selling out during the quarter.
  • Flagship Harbor Advisors sold 218 Hologic shares in Q1 2026, an estimated $16.2K.
  • Flagship Harbor Advisors first reported a position in Hologic in Q2 2018 and held it in 13 quarters.
  • Flagship Harbor Advisors's Hologic position peaked at $678K in Q1 2023.
  • 704 funds tracked by Wall St. Rank held Hologic as of Q1 2026.

Based on Flagship Harbor Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.